HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262

Summary

The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. Regimen F will evaluate the safety and efficacy of a single study drug, ABBV-CLS-7262, in participants with ALS.

Timeline

Start

2023-03-23

Primary completion

2024-10-03

Completion

2024-10-03

Drugs

Indications